Clinical Trial Update: A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy [Phase 4]

View source ↗

Summary

Phase 4 study evaluating long-term safety and effectiveness of vamorolone in boys with Duchenne Muscular Dystrophy; current status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Vamorolone (vamorolone)

Snippet

Sponsor: Santhera Pharmaceuticals | Conditions: Duchenne Muscular Dystrophy | Phase 4 | Status: ACTIVE_NOT_RECRUITING